HDAC has revolutionized the production of a new class of pharmacological agents, HDAC inhibitors (HDACi), which are cytostatic agents that inhibit tumor cell proliferation in culture and persuaded cell cycle arrest, differentiation, and apoptosis in vivo [124]. Here, HDAC9 is linked to neoplasm.